These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2339695)

  • 41. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.
    Prockop DJ; Constantinou CD; Dombrowski KE; Hojima Y; Kadler KE; Kuivaniemi H; Tromp G; Vogel BE
    Am J Med Genet; 1989 Sep; 34(1):60-7. PubMed ID: 2683782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen.
    Valli M; Tenni R; Cetta G
    Matrix; 1990 Jul; 10(3):200-5. PubMed ID: 2215359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta.
    Wenstrup RJ; Lever LW; Phillips CL; Quarles LD
    Am J Med Genet; 1993 Jan; 45(2):228-32. PubMed ID: 8456807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secreted collagen ratios in normal human and osteogenesis imperfecta skin fibroblasts.
    Fraser J; Lancaster GA; Scriver CR
    Connect Tissue Res; 1983; 11(1):57-67. PubMed ID: 6221880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
    Wallis GA; Starman BJ; Zinn AB; Byers PH
    Am J Hum Genet; 1990 Jun; 46(6):1034-40. PubMed ID: 2339700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
    J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered helical structure of a homotrimer of alpha 1(I)chains synthesized by fibroblasts from a variant of osteogenesis imperfecta.
    Deak SB; van der Rest M; Prockop DJ
    Coll Relat Res; 1985 Sep; 5(4):305-13. PubMed ID: 4053561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.
    Raghunath M; Bruckner P; Steinmann B
    J Mol Biol; 1994 Feb; 236(3):940-9. PubMed ID: 8114103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta.
    Kojima T; Miyaishi O; Saga S; Ishiguro N; Tsutsui Y; Iwata H
    J Pathol; 1998 Feb; 184(2):212-8. PubMed ID: 9602714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteogenesis imperfecta: promising beginnings and continuing challenges.
    Hollister DW
    Coll Relat Res; 1981 Feb; 1(2):227-34. PubMed ID: 7049549
    [No Abstract]   [Full Text] [Related]  

  • 52. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
    Constantinou CD; Nielsen KB; Prockop DJ
    J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Biochemical defects in hereditary diseases of the connective tissue (review)].
    Del'vig AA
    Vopr Med Khim; 1986; 32(2):2-14. PubMed ID: 3518233
    [No Abstract]   [Full Text] [Related]  

  • 54. Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.
    Rowe DW; Shapiro JR; Poirier M; Schlesinger S
    J Clin Invest; 1985 Aug; 76(2):604-11. PubMed ID: 4031065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of overmodified type I procollagen in a case of osteogenesis imperfecta.
    Tajima S; Takehana M; Azuma N
    J Dermatol; 1994 Apr; 21(4):219-22. PubMed ID: 8056893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct sequencing of PCR products derived from cDNAs for the pro alpha 1 and pro alpha 2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta.
    Zhuang J; Tromp G; Kuivaniemi H; Castells S; Bugge M; Prockop DJ
    Hum Mutat; 1996; 7(2):89-99. PubMed ID: 8829649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation.
    Forlino A; D'amato E; Valli M; Camera G; Hopkins E; Marini JC; Cetta G; Coviello DA
    Biochem Mol Med; 1997 Oct; 62(1):26-35. PubMed ID: 9367795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
    Pace JM; Chitayat D; Atkinson M; Wilcox WR; Schwarze U; Byers PH
    J Med Genet; 2002 Jan; 39(1):23-9. PubMed ID: 11826020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.
    Byers PH; Shapiro JR; Rowe DW; David KE; Holbrook KA
    J Clin Invest; 1983 Mar; 71(3):689-97. PubMed ID: 6826730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
    Jensen BL; Lund AM
    J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.